Progress toward cancer vaccines

Research output: Contribution to journalArticle


The goal is to make the host immune system responsive to antigens characteristic of cancer cells, just as a classic vaccine makes the system responsive to a viral or bacterial pathogen. Several specific strategies have now reached clinical trials; by varying means, they all seek to establish context - The molecular settings in which an antigen activates T cells.

Original languageEnglish (US)
Pages (from-to)49+50+59-65
JournalHospital practice
Issue number12
StatePublished - Dec 15 2000

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Progress toward cancer vaccines'. Together they form a unique fingerprint.

  • Cite this